Skip to content
BOLUS

Signal from the log

Rightway

155 M$ · Series D and later · United States · Health software

Rightway gère les régimes de médicaments des employeurs en remplaçant la rémunération classique des intermédiaires, qui grossit avec la dépense, par un plafond de dépense garanti et une répercussion intégrale des remises. Des pharmaciens cliniciens orientent les adhérents vers les traitements les moins coûteux. Le Form D du 8 septembre chiffrait déjà le tour à 154 999 891 dollars auprès de six investisseurs, seize jours avant que le communiqué nomme les fonds.

Verified

Announced on , logged by the watch of 24 September 2026.

Operation
Funding round
Announced amount
155 M$
Stage
Series D and later
Country
United States
Sector
Health software

What the log says

Editorial note, in French

Communiqué ouvert, montant relu et fonds nommés.

The investors

Led by Francisco Partners , with Thrive Capital , Khosla Ventures

Provenance
Source edgar,prnewswire
Logged on 24 September 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.

One address, nothing else.

One letter a week, on Fridays: the week's funding rounds, the funds named, the amounts double checked. The list is never sold, one click to unsubscribe. The letter is written in French.

Email confirmation before any subscription. The list is never sold. What Bolus knows about you is written on the privacy page (in French).